Results 191 to 200 of about 1,716,661 (233)

CD47 monoclonal antibody enhances the inhibitory effect of anti-HER2 chimeric antigen receptor macrophages on ovarian cancer. [PDF]

Oncol Lett
Qiao J, Kou Q, Qiu J.
europepmc   +1 more source

Chimeric antigen receptor T‑cell therapy in chronic viral infections: a review. [PDF]

J Transl Med
Han Q, Zhang X, Chen L, Zhang Y.
europepmc   +1 more source

Efficacy and safety of CD30-targeted chimeric antigen receptor T-cell therapy for lymphoma: a meta-analysis. [PDF]

BMC Cancer
Shi J, Lu C, Song C, Wang Q.
europepmc   +1 more source

The development of novel chimeric antigen receptor gamma-delta T cells against multiple myeloma and single-cell RNA sequencing analysis. [PDF]

Br J Haematol
Hong Y, Zhang C, Wang J, Zhang J, Zhu Y, Zhang Y, Shao B, Yang Y, Tan T, Xu P, Chen B.   +10 more
europepmc   +1 more source

IFNγ-induced antigen loss in chimeric antigen receptor-T cell therapy. [PDF]

Front Immunol
Cao M, Alvarez J, Mitra R, Xu M, Baybutt TR, Sun Z, Taylor O, Doermann AS, Staudt RE, Waldman SA, Snook AE.   +10 more
europepmc   +1 more source

Efficacy and safety of chimeric antigen receptor T-cell therapy for plasma cell leukemia. [PDF]

Haematologica
Hu C, Qi N, Wang W, Gale RP, Zhu F, Li H, Cheng H, Cao J, Yan Z, Qi K, Sang W, Zhao K, Chen W.   +12 more
europepmc   +1 more source

The Role of Chimeric Antigen Receptor Regulatory T Cells in Promoting Immune Tolerance in Solid Organ Transplantation: <i>Mechanisms and Therapeutic Potential</i>. [PDF]

Saudi Med J
Alwethaynani MS.
europepmc   +1 more source

Prospects of Chimeric Antigen Receptor T-Cell Therapy in Myelofibrosis: From Immunopathogenesis to Therapeutic Strategies. [PDF]

Cancers (Basel)
Kong L, Fu C, Song L, Wang W, Ji M, Li F, Shi X, Chen W.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chimeric antigen receptors

Nature Biotechnology, 2020
openaire   +2 more sources